LORNOXICAM DRUG PROFILE PDF

Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and. Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory. Lornoxicam is a nonsteroidal anti-inflammatory drug with analgesic properties From: Profiles of Drug Substances, Excipients and Related Methodology,

Author: Vigal Meztizahn
Country: Myanmar
Language: English (Spanish)
Genre: Travel
Published (Last): 3 September 2017
Pages: 373
PDF File Size: 8.35 Mb
ePub File Size: 20.43 Mb
ISBN: 435-2-36928-879-8
Downloads: 94659
Price: Free* [*Free Regsitration Required]
Uploader: Faunris

Gentamicin C1a The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Gentamicin C1a. Indometacin Prostaglandin D 2 Antagonists: Cephalothin Group The risk or severity of nephrotoxicity can be drjg when Cephalothin Group is combined with Lornoxicam. Gemeprost Lornoxicam may decrease the excretion rate of Gemeprost which could result in a higher serum level. Ketoconazole The metabolism of Lornoxicam can be decreased when combined with Ketoconazole.

Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Lornoxicam. Hydrocortisone succinate The risk or severity of gastrointestinal irritation can be increased prpfile Hydrocortisone succinate is combined with Lornoxicam.

You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. Etacrynic acid The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Lornoxicam.

Captopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lornoxicam is combined with Captopril. Etravirine The metabolism of Lornoxicam can be increased when combined with Etravirine.

Cinnamaldehyde Lornoxicam may decrease the excretion rate drrug Cinnamaldehyde which could result in a higher serum lornoxicxm. Drugs A – Z. Parenteral Pain relief Adult: Please keep your comments brief and relevant. Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Lornoxicam. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Bevantolol Lornoxicam may decrease the antihypertensive activities of Bevantolol.

  2004-2005 ALABAMA BANDMATERS ASSOCIATION PDF

Increased risk of lithium toxicity. Celiprolol Lornoxicam may decrease the antihypertensive activities of Celiprolol. Azosemide The therapeutic efficacy of Azosemide can be decreased when used in combination with Lornoxicam. Harmaline The risk or severity of hypertension can be increased when Lornoxicam is combined with Harmaline.

Clotrimazole The metabolism of Lornoxicam can be decreased when combined with Clotrimazole. Flutamide Lornoxicam may decrease the excretion rate of Flutamide which could result in a higher serum level.

Efavirenz The metabolism of Lornoxicam can be decreased when combined with Efavirenz.

Lornoxicam – DrugBank

Armodafinil The metabolism of Lornoxicam can be decreased when combined with Armodafinil. Mephenytoin The metabolism of Lornoxicam can be decreased when combined with Mephenytoin.

Fluticasone The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Lornoxicam. Icatibant Lornoxicam may decrease the excretion rate of Icatibant which could result in a higher serum level.

Mefenorex The risk or severity of hypertension can be increased when Lornoxicam is combined with Mefenorex. Brexpiprazole The risk or severity of hypertension can be increased when Lornoxicam is combined with Brexpiprazole.

Guanoxabenz The therapeutic efficacy of Guanoxabenz can be decreased when used in combination with Lornoxicam. Lornoxicam brands in India. Latanoprost The therapeutic efficacy of Latanoprost can be decreased when used in combination with Lornoxicam.

There was a problem providing the content you requested

Metaxalone Lornoxicam may decrease the excretion rate of Metaxalone which could result in a higher serum level. Choline magnesium trisalicylate The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lornoxicam. Cortisone The risk or severity of gastrointestinal irritation can be increased when Cortisone is combined with Lornoxicam. Fluticasone furoate The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Lornoxicam.

Magnesium sulfate The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Lornoxicam. Osteoarthritis is one of the commonest joint disorder and occurs as we age due to wear and tear of a joint. Cefacetrile The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Lornoxicam.

  CITRIX BRANCH REPEATER PDF

Emapalumab The metabolism of Lornoxicam can be increased when combined with Emapalumab. Brivaracetam Lornoxicam may decrease the excretion rate of Brivaracetam which could result in a higher serum level. All comments are however constantly reviewed for spam and irrelevant material such as product or personal advertisements, email addresses, telephone numbers and website address. Ibuproxam The risk or severity of adverse effects can be increased when Lornoxicam is combined with Ibuproxam.

Iobenguane sulfate I Lornoxicam may decrease the excretion rate of Iobenguane sulfate I which could result in a higher serum level. Dimercaprol Lornoxicam may decrease the excretion rate of Dimercaprol which could result in a higher serum level. Eucalyptus oil Lornoxicam may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.

Darexaban The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Darexaban.

Genistein The metabolism of Lornoxicam can be decreased when profils with Genistein. Azathioprine Lornoxicam may decrease the excretion rate of Azathioprine which could result in a higher serum level.

It comes as a solution for injection to be administered by a healthcare provider into the vein or muscle. Corifollitropin alfa Lornoxicam may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.

Lornoxicam

Medroxyprogesterone acetate Lornoxicam may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level. Amprenavir Lornkxicam metabolism of Lornoxicam can be decreased when combined with Amprenavir.

Skin death and rash. Gemcitabine Lornoxicam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.